Skip to main content
Apply

Respiratory and Infectious Diseases

Open Main MenuClose Main Menu
  • Project/Pilot Project Leaders

    Butcher, Joshua Thomas, NIH/NIA, K01AG064121, Skeletal Muscle as a Target for Cardio-Metabolic Disease in Sarcopenic Obesity, 08/01/2020 – 05/31/2025, $643,860.

     

    Butcher, Joshua Thomas, OSU CVM, Effect of an exercise mimetic on brain function, 10/01/2020 – 09/30/2021, $10,000.

     

    Burgett, Anthony/Earl Blewett, NIH/NIAID, R01AI154274, Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach” 04/08/2021 – 03/31/26, $2,002,666.

     

    Cabeen, Matthew, NIH, R35GM138018, Stress sensing and processing by bacterial cytoplasmic megacomplexes, 09/15/2020-08/31/2025, $1,712,063.

     

    Cabeen, Matthew, Oklahoma Center for the Advancement of Science and Technology, Regulation of P. aeruginosa biofilm formation by a DNA-binding protein, 10/01/20-9/30/23, $95,000.

     

    Deng, Junpeng, NIH, R21AI149295, Structure function studies of a molecular complex for generating viral membrane, 05/22/2020-04/30/2022, $411,400.

     

    Duerfeldt, Adam S., NIH, 1R01EY030472-01A1, Small Molecule PPAR-alpha Agonism as a Novel Approach to Treat Eye Vascular Diseases, 05/01/2020-04/30/2025, $2,290,005.

     

    Kovats, Susan, Presbyterian Health Foundation, Impact of immune-modulating therapy on respiratory virus infection in the murine EAE model of multiple sclerosis, 07/01/20 – 06/30/21, $140,000

     

    Lacombe, Veronique, Oklahoma Center for the Advancement of Science and Technology, The Sarcoplasmic Reticulum Calcium ATPase Pump as a Major Regulator of Glucose Metabolism: A Novel Target for Diabetic Patients, 07/01/2020 - 06/30/2023, $134,601.

     

    Lacombe, Veronique, OSU CVM, Novel therapeutic targets to improve cardiorespiratory outcomes during COVID-19 infection and diabetes, 10/15/2020 - 10/14/2021, $20,000.

     

    Lin, Dingbo (Daniel), USDA/NIFA, 2021-67018-34023, Watermelon juice promotes the gut microbiome homeostasis. 01/01/2021-12/31/2022. $200,000.

     

    Lutter, Erika, Oklahoma Center for the Advancement of Science and Technology, Manipulation of Host Kinases by Chlamydia Trachomatis, 07/01/2020 - 06/30/2023, $135,000.

     

    McCall, Laura-Isobel, PhRMA foundation, Meeting the translational need for biomarkers of Chagas disease cure, 07/01/20-06/30/21 $100,000.

     

    Miller, Craig, Morris Animal Foundation, D21FE-809, An innovative approach to replicate the Cytauxzoon felis lifecycle in vitro, 10/01/2020 – 09/30/2021, $10,800.

     

    Rajan, Rakhi, Oklahoma Center for the Advancement of Science and Technology, Protein Engineering to Develop Stringent CRISPR-Cas Genome Tools, 07/01/2020 - 06/30/2023, $135,000.

  • Mentors/Core Directors

    Coggeshall, Kenneth, Mark, NIH, 3U19AI062629-17S2, Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax, 06/08/2020-08/31/2021, $916,783

     

    Coggeshall, Kenneth, Mark, NIH, 3U19AI062629-17S1, Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax, 09/01/2020-08/31/2022, $476,466

     

    Jones, Clinton, NIH, 5R01NS111167-02, Stress-Mediated Regulation of HSV-1 Reactivation from Latency, 04/01/2020-01/31/2025, $1,750,000.

     

    Jones, Clinton, USDA/NIFA, 2020-06435, Maintenance of bovine herpesvirus 1 latency by viral and cellular factors, 7/1/2021-6/30/2025, $497,000.

     

    Liu, Lin, NIH/NIAID, R21AI152004, Lnc-PINK regulation of innate immunity in lung epithelial cells, 03/05/2021 – 02/28/2023, $411,400.

     

    Liu, Lin, Oklahoma Center for Adult Stem Cell Research, Development of a COVID-19 human lung tissue model for drug screen using iPSCs, 01/01/2021 – 12/31/2021, $168,000.

     

    Liu, Lin, Oklahoma Center for the Advancement of Science and Technology HR20-050, Role of Tankryase 2 in Lung Innate Immunity, 10/01/2020 – 09/30/2023,  $135,000,

     

    Metcalf, Jordan P., Veterans Administration Merit Review Grant, I01BX005023, Reversing Cigarette Smoke-Induced Antiviral Immunosuppression, 10/01/2020-09/30/2024, $949,344.

  • Center Investigators

    Waters, Matthew, Presbyterian Health Foundation, COPD-dependent Changes in Human Airway Stem/Progenitor Cell Function, 07/01/20-06/30/21, $50,000.

     

    Waters, Matthew, Presbyterian Health Foundation, SARS-CoV-2 Host-Virus Interactions in Old vs. Young Human Airway Epithelium, 57/01/20-08/30/21, $35,000.

MENUCLOSE